FLUORESCITE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fluorescite, and when can generic versions of Fluorescite launch?
Fluorescite is a drug marketed by Alcon Labs Inc and is included in one NDA.
The generic ingredient in FLUORESCITE is fluorescein sodium. There are five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the fluorescein sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fluorescite
A generic version of FLUORESCITE was approved as fluorescein sodium by NEXUS PHARMS on September 25th, 2023.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLUORESCITE?
- What are the global sales for FLUORESCITE?
- What is Average Wholesale Price for FLUORESCITE?
Summary for FLUORESCITE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 43 |
| Clinical Trials: | 10 |
| Patent Applications: | 628 |
| What excipients (inactive ingredients) are in FLUORESCITE? | FLUORESCITE excipients list |
| DailyMed Link: | FLUORESCITE at DailyMed |
Recent Clinical Trials for FLUORESCITE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Aditya Kaza | Phase 2 |
| UpTru Inc. | Phase 1 |
Pharmacology for FLUORESCITE
| Drug Class | Diagnostic Dye |
| Mechanism of Action | Dyes |
US Patents and Regulatory Information for FLUORESCITE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon Labs Inc | FLUORESCITE | fluorescein sodium | INJECTABLE;INTRAVENOUS | 021980-001 | Mar 28, 2006 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
